Quotes 5-day view Delayed Nyse
02/26/2021
03/01/2021
03/02/2021
03/03/2021
03/04/2021
Date
83.1(c)
85.77(c)
86.28(c)
84.25(c)
81.88(c)
Last
2 641 873
3 184 609
3 315 772
2 514 292
2 764 010
Volume
-1.04% +3.21% +0.59% -2.35% -2.81% Change
Sales 2021
5 054 M - -
Net income 2021
1 181 M - -
Net cash position 2021
1 413 M - -
P/E ratio 2021
42,6x
Yield 2021
-
Sales 2022
5 650 M - -
Net income 2022
1 386 M - -
Net cash position 2022
2 407 M - -
P/E ratio 2022
35,8x
Yield 2022
-
Capitalization
51 136 M 51 136 M -
EV / Sales 2021
9,84x
EV / Sales 2022
8,63x
Nbr of Employees
14 900
Free-Float
97,4%
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- hemodynamic monitoring systems (61.4%);
- heart valves and surgery products (20.4%);
- other (18.1%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the...
Notations Surperformance© of Edwards Lifesciences Corporation
Trading Rating : Investor Rating :
All news about EDWARDS LIFESCIENCES CORPORATION
News in other languages on EDWARDS LIFESCIENCES CORPORATION
Analyst Recommendations on EDWARDS LIFESCIENCES CORPORATION
Chart EDWARDS LIFESCIENCES CORPORATION
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends EDWARDS LIFESCIENCES CORPORATION
Short Term Mid-Term Long Term Trends Bearish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
25
Average target price
92,60 $
Last Close Price
81,88 $
Spread / Highest target
35,6%
Spread / Average Target
13,1%
Spread / Lowest Target
-13,3%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
